Etienne Belanger

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Journal: mBio

Published: July 29, 2026

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

HIV-1 soluble gp120 in cerebrospinal fluid is associated with poorer motor domain neurocognitive performance in virally suppressed people with HIV.

HIV-1 soluble gp120 in cerebrospinal fluid is associated with poorer motor domain neurocognitive performance in virally suppressed people with HIV.

Journal: AIDS (London, England)

Published: December 17, 2025

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.

Journal: mBio

Published: September 08, 2025

Long-term performance of a woodchip-based field-scale biofilter for arsenic removal from neutral mine drainage under cold climate.

Long-term performance of a woodchip-based field-scale biofilter for arsenic removal from neutral mine drainage under cold climate.

Journal: Water research

Published: July 17, 2025

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2.

Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2.

Journal: Viruses

Published: April 04, 2025

A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120.

A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120.

Journal: Journal of virology

Published: March 27, 2025

LYPLAL1 enzyme activity is linked to hepatic glucose metabolism.

LYPLAL1 enzyme activity is linked to hepatic glucose metabolism.

Journal: Biochemical and biophysical research communications

Published: December 05, 2024

Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.

Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.

Journal: Virology

Published: October 30, 2024

The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC.

The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC.

Journal: Nature communications

Published: September 12, 2024

The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC.

The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC.

Journal: bioRxiv : the preprint server for biology

Published: September 10, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026